Gregory R Friberg insider trades
Open-market stock purchases and sales by Gregory R Friberg, EVP, Chief R&D Officer at Biomarin Pharmaceutical Inc, from SEC Form 4 filings since Sep 30, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 30, 2026 | BMRN Biomarin Pharmaceutical Inc | Sold (not open market) | $245K |
| May 7, 2026 | BMRN Biomarin Pharmaceutical Inc | Sold | $177K |
| Mar 17, 2026 | BMRN Biomarin Pharmaceutical Inc | Sold (not open market) | $91.3K |
| Mar 16, 2026 | BMRN Biomarin Pharmaceutical Inc | Bought (not open market) | — |
| Mar 16, 2026 | BMRN Biomarin Pharmaceutical Inc | Bought (not open market) | — |
| Feb 26, 2026 | BMRN Biomarin Pharmaceutical Inc | Sold | $382K |
Companies traded
- BMRN Biomarin Pharmaceutical Inc: 2 sales, last Sep 30, 2026